Naoko Chayahara

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Yoshinori Imamura, Toru Mukohara, Yohei Shimono et al. · Oncology Reports · 2015 · 858 citations · Full text

Medicine, Cancer Biology, Oncology +15

Lenvatinib for Anaplastic Thyroid Cancer

Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki et al. · Frontiers in Oncology · 2017 · 192 citations · Full text

Medicine, Oncology, Pharmacology +12

A Phase II Study of the Safety and Efficacy of Lenvatinib in Patients with Advanced Thyroid Cancer

Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki et al. · Future Oncology · 2019 · 140 citations · Full text

Medicine, Oncology, Pharmacology +16

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients

Yutaka Fujiwara, Naomi Kiyota, Naoko Chayahara et al. · Investigational New Drugs · 2011 · 61 citations · Full text

Medicine, Oncology, Pharmacology +15

Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer

Yutaka Fujiwara, Takashi Kobayashi, Naoko Chayahara et al. · PLoS ONE · 2014 · 59 citations · Full text

Life Sciences, Biochemistry, Oncology +17